The company, which plans to grow to more than 60 employees next year, wants to become the first domestic producer of molybdenum-99, an isotope often used in medical imaging but sourced from foreign nuclear reactors.

“Our entire team is excited about this move,” SHINE CEO Greg Piefer said. “The relationship between the city and SHINE has always been our top priority, and now it’ll be home.”

See more:

Read the Xconomy story here.